Genetic Testing Market Surpass US$ 18 Billion by 2026 : Moderate CAGR at 11%

Pune, India -- (SBWire) -- 05/10/2019 --The Global Genetic Testing Market is estimated to grow at CAGR above 11 % over the forecast time frame 2019-2026 and reach the market value around USD 18 billion by 2026.

The genetic test is a gene study examining a blood sample or a sample of other fluid cells from the genetic material. The study focuses on hereditary and gene variations and numbers of chromosomes which are used to detect genetic disorders and to select specific therapies to treat these genetic disorders. Genetic testing includes several techniques like comparative genomic hybridization, on-site fluorescence, karyotyping, immunohistochemistry and others.

Free Download Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1351

Some new genetic testing techniques, increased efficiency and accuracy are expected to provide positive opportunities for global genetic testing. Moreover, in these regions, emerging markets have a good prospect of growing genetic testing because of the growing patient pool and awareness. Some of the main trends in the genetic testing market were the shift from the focus on clinical science to bioinformatics and an increasing popularity in genetic testing technology.

Market Snapshots

In the future, the worldwide market for genetic testing is expected to record considerable growth as genetic disorder & cancer increases. In the predicted period there are also expected to be increased demand for personalized medicine and the increasing use of genetic testing in oncology to boost market growth. However, the growth of the market of genetic testing during the forecast period is expected to hinder high costs of genetic testing and stringent regulatory requirements for product approvals. Conversely, untapped developing countries ' emerging markets are expected to provide market players with compensatory opportunities. Consequently, the global market share for genetic testing is expected to increase these drivers and chances.

The market is segmented on a type-based basis into predictive, carrier, prenatal and newborn tests, diagnostic tests, pharmacogenomic and other tests. Currently, the diagnostic test segment leads with revenue in 2018 and its dominance over the projected period is expected to continue. This is because people are increasingly aware of health and the incidence of mortality due to genetic diseases worldwide. On the other hand, during the forecast period the pharmacogenomic test segment is expected to be the highest CAGR. This is largely because pharmaceutical companies are increasingly applying drugs and developing them.

Regional Stance

The markets in North America, Europe, Asia-Pacific and LAMEA are assessed on the grounds of geography. North America was the global leader in the genetic testing market in 2018 and will dominate the forecasting period. The majority of key players in this region are attributed to this. However, as a result of the increase of accessibility, increased health expenditure and increased attention to early screening of genetic disorders, Asia-Pacific is expected to grow in the highest CAGR over the projected timeframe. In addition, the number of visitors to the cholera-affected countries is rising and the need for immunization is increasing in turn.

View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/genetic-testing-market

Key Players & Strategies

23andMe, Abbott Molecular, Biocartis, BioHelix, Bayer Diagnostics, BioMerieux, BGI, Celera Genomics, Cepheid, Counsyl, deCODEme, Genentech, Genomictree, HTG Molecular Diagnostics, Luminex, MolecularTM, IntegraGen, LabCorp diagnostics, Myriad, Natera, PacBio, Pathway Geneomaics, Qiagen, Roche Diagnostic is among the most eminent players in the global genetic testing market. Industry players focus on the strategic expansion of their product portfolio through acquisitions, fusions and collaborations. Roche, for example, in December 2018, acquired the Non-invasive Prenatal (NIPT) and cell-free DNA testing services market Ariosa Diagnostics, a provider of molecular diagnostic testing services.

The increasing prevalence in the genetic testing industry will drive a growing global genetic testing industry for diseases like cancer, cystic fibrosis, Alzheimer's and others. Increasing genetical tests and genetic mutation identification before their onset will further increase the industry's growth over the forecast period. Due to the increased adoption of genetic testing by physicians in clinical care, the industry should see rapid growth in future. The availability of direct consumer (DTC) regulatory aid and on-going technological advances allow industry players to maintain a position on the market.

Browse All official Market Research Reports Press Releases@ https://www.acumenresearchandconsulting.com/press-releases

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Genetic Testing
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Genetic Testing Market By Type
1.2.2.1. Global Genetic Testing Market Revenue and Growth Rate Comparison By Type (2015-2026)
1.2.2.2. Global Genetic Testing Market Revenue Share By Type in 2017
1.2.2.3. Predictive Testing
1.2.2.4. Prenatal & Newborn Testing
1.2.2.5. Diagnostic Testing
1.2.2.6. Carrier Testing
1.2.2.7. Pharmacogenomic Testing
1.2.2.8. Others
1.2.3. Genetic Testing Market By Technology
1.2.3.1. Global Genetic Testing Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.3.2. Global Genetic Testing Market Revenue Share By Technology in 2017
1.2.3.3. Biochemical Testing
1.2.3.4. Cytogenetic Testing/ Chromosome Analysis
1.2.3.5. Molecular Testing
1.2.3.6. DNA Sequencing
1.2.3.7. Others
1.2.4. Genetic Testing Market By Application
1.2.4.1. Global Genetic Testing Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.4.2. Global Genetic Testing Market Revenue Share By Application in 2017
1.2.4.3. Genetic Disease Diagnosis
1.2.4.4. Cardiovascular Disease Diagnosis
1.2.4.5. Chromosome Analysis
1.2.4.6. Others
1.2.5. Genetic Testing Market by Geography
1.2.5.1. Global Genetic Testing Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Genetic Testing Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Genetic Testing Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Genetic Testing Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Genetic Testing Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Genetic Testing Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter's Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Genetic Testing Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Genetic Testing Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Genetic Testing Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Genetic Testing Major Manufacturers in 2017

CHAPTER 4. GENETIC TESTING MARKET BY TYPE

4.1. Global Genetic Testing Revenue By Type
4.2. Predictive Testing
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Prenatal & Newborn Testing
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Diagnostic Testing
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Carrier Testing
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Pharmacogenomic Testing
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.7. Others
4.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. GENETIC TESTING MARKET BY TECHNOLOGY

5.1. Global Genetic Testing Revenue By Technology
5.2. Biochemical Testing
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Cytogenetic Testing/ Chromosome Analysis
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Molecular Testing
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. DNA Sequencing
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.6. Others
5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. GENETIC TESTING MARKET BY APPLICATION

6.1. Global Genetic Testing Revenue By Application
6.2. Genetic Disease Diagnosis
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Cardiovascular Disease Diagnosis
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Chromosome Analysis
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Others
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA GENETIC TESTING MARKET BY COUNTRY

7.1. North America Genetic Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Genetic Testing Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Genetic Testing Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE GENETIC TESTING MARKET BY COUNTRY

8.1. Europe Genetic Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Genetic Testing Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC GENETIC TESTING MARKET BY COUNTRY

9.1. Asia-Pacific Genetic Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Genetic Testing Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA GENETIC TESTING MARKET BY COUNTRY

10.1. Latin America Genetic Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Genetic Testing Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST GENETIC TESTING MARKET BY COUNTRY

11.1. Middle East Genetic Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Genetic Testing Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA GENETIC TESTING MARKET BY COUNTRY

12.1. Africa Genetic Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Genetic Testing Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. 23andMe
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Product Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Abbott Molecular
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Product Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Biocartis
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Product Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. BioHelix
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Product Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Bayer Diagnostics
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Product Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. BioMerieux
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Product Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. BGI
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Product Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Celera Genomics
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Product Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Cepheid
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Product Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Counsyl
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Product Portfolio
13.10.5. Key Developments
13.10.6. Strategies
13.11. deCODEme
13.11.1. Company Snapshot
13.11.2. Overview
13.11.3. Financial Overview
13.11.4. Product Portfolio
13.11.5. Key Developments
13.11.6. Strategies
13.12. Genentech
13.12.1. Company Snapshot
13.12.2. Overview
13.12.3. Financial Overview
13.12.4. Product Portfolio
13.12.5. Key Developments
13.12.6. Strategies
13.13. Genomictree
13.13.1. Company Snapshot
13.13.2. Overview
13.13.3. Financial Overview
13.13.4. Product Portfolio
13.13.5. Key Developments
13.13.6. Strategies
13.14. HTG Molecular Diagnostics
13.14.1. Company Snapshot
13.14.2. Overview
13.14.3. Financial Overview
13.14.4. Product Portfolio
13.14.5. Key Developments
13.14.6. Strategies
13.15. Luminex
13.15.1. Company Snapshot
13.15.2. Overview
13.15.3. Financial Overview
13.15.4. Product Portfolio
13.15.5. Key Developments
13.15.6. Strategies
13.16. MolecularMD
13.16.1. Company Snapshot
13.16.2. Overview
13.16.3. Financial Overview
13.16.4. Product Portfolio
13.16.5. Key Developments
13.16.6. Strategies
13.17. IntegraGen
13.17.1. Company Snapshot
13.17.2. Overview
13.17.3. Financial Overview
13.17.4. Product Portfolio
13.17.5. Key Developments
13.17.6. Strategies
13.18. LabCorp diagnostics
13.18.1. Company Snapshot
13.18.2. Overview
13.18.3. Financial Overview
13.18.4. Product Portfolio
13.18.5. Key Developments
13.18.6. Strategies
13.19. Myriad
13.19.1. Company Snapshot
13.19.2. Overview
13.19.3. Financial Overview
13.19.4. Product Portfolio
13.19.5. Key Developments
13.19.6. Strategies
13.20. Natera
13.20.1. Company Snapshot
13.20.2. Overview
13.20.3. Financial Overview
13.20.4. Product Portfolio
13.20.5. Key Developments
13.20.6. Strategies
13.21. PacBio
13.21.1. Company Snapshot
13.21.2. Overview
13.21.3. Financial Overview
13.21.4. Product Portfolio
13.21.5. Key Developments
13.21.6. Strategies
13.22. Pathway Genomics
13.22.1. Company Snapshot
13.22.2. Overview
13.22.3. Financial Overview
13.22.4. Product Portfolio
13.22.5. Key Developments
13.22.6. Strategies
13.23. Qiagen
13.23.1. Company Snapshot
13.23.2. Overview
13.23.3. Financial Overview
13.23.4. Product Portfolio
13.23.5. Key Developments
13.23.6. Strategies
13.24. Roche Diagnostic
13.24.1. Company Snapshot
13.24.2. Overview
13.24.3. Financial Overview
13.24.4. Product Portfolio
13.24.5. Key Developments
13.24.6. Strategies
13.25. Others
13.25.1. Company Snapshot
13.25.2. Overview
13.25.3. Financial Overview
13.25.4. Product Portfolio
13.25.5. Key Developments
13.25.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

INQUIRY BEFORE BUYING@ https://www.acumenresearchandconsulting.com/inquiry-before-buying/1351

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this Premium Research Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1351

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.